Clinical Trial

Improved Selection of Elderly (> 65 Years) for Kidney Transplantation

Study acronym: QUESTION65
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Kidney transplantation has been shown to provide improved survival even in patients older than 70 years of age. The purpose of the study is to determine whether kidney transplantation provides any improvement of health related quality of life (HRQOL) in patients over the age of 65 years. HRQOL wil be monitored using the Kidney Disease and Quality of Life (KDQOL-SF)form. Patients will be recruited at the time of acceptance to the Norwegian transplant wait list and followed every 6 months until transplantation. Thereafter a new form will be completed after 10 weeks post transplant, 6 months, 1 year, 3 years and 5 years. In addition the study will explore the transplant candidates expectations in a qualitative study design and explore the relationship between pre-transplant comorbidity, HRQOL and survival.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2013-01-02; most recent amendment 2020-04-22.
Status change: Recruiting → Active, Not Recruiting 2016-12-22
Trial Details
NCT Number NCT01760733
Lead Sponsor Sykehuset Telemark
Collaborators: Oslo University Hospital
Conditions Quality of Life, End Stage Renal Disease, End Stage Renal Failure on Dialysis
Enrollment 289 participants
Start Date 2012-12
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2020-04-24